Verici DX

Verici DX is a biotechnology company based in Franklin, Tennessee. The company employs 20 people and generates over $10,000 in annual revenue. Verici DX specializes in developing prognostic tests to assess how patients will respond to organ transplants. These tests provide insights into both the current and future response of patients to transplantation procedures. The company's focus on prognostic testing distinguishes it within the organ transplant field. Their tests aim to improve patient outcomes and guide clinical decision-making by offering a deeper understanding of individual patient responses to transplantation. For more information about Verici DX and its services, please visit vericidx.com.